Skip to content
Home/Companies/Biotech/ASTRA Therapeutics

ASTRA Therapeutics

Biotech·Germany·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns ASTRA Therapeutics?

ASTRA Therapeutics is currently owned by MIG Capital through MIG Fonds 17 (2022 vintage), since 2025.

Hand-verified · updated 2026-07-03

MIG Capital
Investor
MIG Capital
MIG Fonds 17 · 2022 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from MIG Fonds 17

Other portfolio companies in the same fund.

GlassPoint
Active
EnergyUS· 2024
HawkCell
Active
MedTechFrance· 2024
SciRhom
Active
BiotechGermany· 2024
Look Up Space
Active
Deep TechFrance· 2023
TALPA Solutions
TALPA Solutions
Active
SoftwareGermany· 2023
German Bionic
German Bionic
Exited 2025
IndustrialsGermany· 2020
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track ASTRA Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy ASTRA Therapeutics?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on ASTRA Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue